Table 5 Hemorrhagic complications during 3-month follow up
Items | Intracoronary prourokinase group (N = 25) | Control group (N = 25) | P value |
|---|---|---|---|
Intracranial hemorrhage, No. (%) | 0 (0.0) | 0 (0.0) | – |
Hematemesis, No. (%) | 0 (0.0) | 0 (0.0) | – |
Hemoptysis, No. (%) | 0 (0.0) | 0 (0.0) | – |
Hematuria, No. (%) | 0 (0.0) | 0 (0.0) | – |
Dermatorrhagia, No. (%) | 1 (4.0) | 0 (0.0) | 1.000 |
Hemorrhage of puncture site, No. (%) | 0 (0.0) | 0 (0.0) | – |
Gingival bleeding, No. (%) | 2 (8.0) | 1 (4.0) | 1.000 |